Driedonks Tom A P, Mol Sanne, de Bruin Sanne, Peters Anna-Linda, Zhang Xiaogang, Lindenbergh Marthe F S, Beuger Boukje M, van Stalborch Anne-Marieke D, Spaan Thom, de Jong Esther C, van der Vries Erhard, Margadant Coert, van Bruggen Robin, Vlaar Alexander P J, Groot Kormelink Tom, Nolte-'t Hoen Esther N M
Department Of Biochemistry & Cell Biology, Faculty of Veterinary Medicine, Utrecht University, Utrecht, The Netherlands.
Department Of Experimental Immunology, Amsterdam University Medical Centers, University of Amsterdam, Amsterdam, The Netherlands.
J Extracell Vesicles. 2020 May 26;9(1):1764213. doi: 10.1080/20013078.2020.1764213.
Major efforts are made to characterize the presence of microRNA (miRNA) and messenger RNA in blood plasma to discover novel disease-associated biomarkers. MiRNAs in plasma are associated to several types of macromolecular structures, including extracellular vesicles (EV), lipoprotein particles (LPP) and ribonucleoprotein particles (RNP). RNAs in these complexes are recovered at variable efficiency by commonly used EV- and RNA isolation methods, which causes biases and inconsistencies in miRNA quantitation. Besides miRNAs, various other non-coding RNA species are contained in EV and present within the pool of plasma extracellular RNA. Members of the Y-RNA family have been detected in EV from various cell types and are among the most abundant non-coding RNA types in plasma. We previously showed that shuttling of full-length Y-RNA into EV released by immune cells is modulated by microbial stimulation. This indicated that Y-RNAs could contribute to the functional properties of EV in immune cell communication and that EV-associated Y-RNAs could have biomarker potential in immune-related diseases. Here, we investigated which macromolecular structures in plasma contain full length Y-RNA and whether the levels of three Y-RNA subtypes in plasma (Y1, Y3 and Y4) change during systemic inflammation. Our data indicate that the majority of full length Y-RNA in plasma is stably associated to EV. Moreover, we discovered that EV from different blood-related cell types contain cell-type-specific Y-RNA subtype ratios. Using a human model for systemic inflammation, we show that the neutrophil-specific Y4/Y3 ratios and PBMC-specific Y3/Y1 ratios were significantly altered after induction of inflammation. The plasma Y-RNA ratios strongly correlated with the number and type of immune cells during systemic inflammation. Cell-type-specific "Y-RNA signatures" in plasma EV can be determined without prior enrichment for EV, and may be further explored as simple and fast test for diagnosis of inflammatory responses or other immune-related diseases.
人们付出了巨大努力来表征血浆中的微小RNA(miRNA)和信使RNA,以发现新的疾病相关生物标志物。血浆中的miRNA与几种大分子结构有关,包括细胞外囊泡(EV)、脂蛋白颗粒(LPP)和核糖核蛋白颗粒(RNP)。常用的EV和RNA分离方法以不同效率回收这些复合物中的RNA,这导致miRNA定量存在偏差和不一致。除了miRNA,EV中还包含各种其他非编码RNA种类,并且存在于血浆细胞外RNA池中。Y-RNA家族的成员已在来自各种细胞类型的EV中被检测到,并且是血浆中最丰富的非编码RNA类型之一。我们之前表明,全长Y-RNA穿梭到免疫细胞释放的EV中受微生物刺激调节。这表明Y-RNA可能有助于EV在免疫细胞通讯中的功能特性,并且与EV相关的Y-RNA在免疫相关疾病中可能具有生物标志物潜力。在这里,我们研究了血浆中的哪些大分子结构含有全长Y-RNA,以及血浆中三种Y-RNA亚型(Y1、Y3和Y4)的水平在全身炎症期间是否发生变化。我们的数据表明,血浆中大多数全长Y-RNA与EV稳定相关。此外,我们发现来自不同血液相关细胞类型的EV含有细胞类型特异性的Y-RNA亚型比率。使用人类全身炎症模型,我们表明炎症诱导后,中性粒细胞特异性的Y4/Y3比率和外周血单核细胞特异性的Y3/Y1比率显著改变。全身炎症期间,血浆Y-RNA比率与免疫细胞的数量和类型密切相关。无需事先富集EV即可确定血浆EV中细胞类型特异性的“Y-RNA特征”,并且可以进一步探索将其作为诊断炎症反应或其他免疫相关疾病的简单快速检测方法。